Evelyn Partners Investment Management LLP Raises Holdings in GE HealthCare Technologies Inc. $GEHC

Evelyn Partners Investment Management LLP raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 28.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 187,196 shares of the company’s stock after acquiring an additional 41,473 shares during the period. Evelyn Partners Investment Management LLP’s holdings in GE HealthCare Technologies were worth $13,866,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. N.E.W. Advisory Services LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Allianz SE grew its stake in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after buying an additional 218 shares during the period. Gladwyn Financial Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $34,000. Game Plan Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after acquiring an additional 375 shares during the period. Finally, Zions Bancorporation National Association UT acquired a new position in shares of GE HealthCare Technologies during the 1st quarter valued at $42,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 2.3%

GEHC stock opened at $76.45 on Friday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a 50 day simple moving average of $74.70 and a 200-day simple moving average of $73.82. The company has a market capitalization of $34.82 billion, a P/E ratio of 15.80, a PEG ratio of 3.12 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 24th were paid a dividend of $0.035 per share. The ex-dividend date was Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a report on Friday. Barclays began coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Morgan Stanley increased their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $86.45.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.